Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K B Meyer

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Immunology|March 26, 1999
Induction of the Igkappa 3' enhancer by distinct pathways can be inhibited by cross-linking of the CD40 receptorK B Meyer
Advances in Renal Replacement Therapy|April 1, 1995
The outcomes of ESRD and its treatmentK B Meyer
European Journal of Immunology|May 29, 1998
PMA/ionomycin induces Ig kappa 3' enhancer activity which is in part mediated by a unique NFAT transcription complexK B Meyer, J Ireland
Nucleic Acids Research|May 11, 1994
Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active coreK B Meyer, J Ireland
Biochemical Society Transactions|May 1, 1997
A NF-AT related protein is implicated in the induction of the immunoglobulin kappa 3'-enhancer activity after B cell stimulationK B Meyer, J Ireland
Journal of the American Society of Nephrology : JASN|July 11, 2001
Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular diseaseK B Meyer, A S Levey
The New England Journal of Medicine|July 23, 1987
Screening for HIV: can we afford the false positive rate?K B Meyer, S G Pauker
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1995
Assessing health status in a dialysis clinicM M Chapman, K B Meyer
European Journal of Immunology|February 12, 2000
Post-transcriptional regulation of E2A proteins via lipopolysaccharide and CD40 signalingK B Meyer, D A Mufti
Mineral and Electrolyte Metabolism|January 1, 1994
Cisplatin nephrotoxicityK B Meyer, N E Madias
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Immunology|March 26, 1999
Induction of the Igkappa 3' enhancer by distinct pathways can be inhibited by cross-linking of the CD40 receptorK B Meyer
Advances in Renal Replacement Therapy|April 1, 1995
The outcomes of ESRD and its treatmentK B Meyer
European Journal of Immunology|May 29, 1998
PMA/ionomycin induces Ig kappa 3' enhancer activity which is in part mediated by a unique NFAT transcription complexK B Meyer, J Ireland
Nucleic Acids Research|May 11, 1994
Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active coreK B Meyer, J Ireland
Biochemical Society Transactions|May 1, 1997
A NF-AT related protein is implicated in the induction of the immunoglobulin kappa 3'-enhancer activity after B cell stimulationK B Meyer, J Ireland
Journal of the American Society of Nephrology : JASN|July 11, 2001
Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular diseaseK B Meyer, A S Levey
The New England Journal of Medicine|July 23, 1987
Screening for HIV: can we afford the false positive rate?K B Meyer, S G Pauker
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1995
Assessing health status in a dialysis clinicM M Chapman, K B Meyer
European Journal of Immunology|February 12, 2000
Post-transcriptional regulation of E2A proteins via lipopolysaccharide and CD40 signalingK B Meyer, D A Mufti
Mineral and Electrolyte Metabolism|January 1, 1994
Cisplatin nephrotoxicityK B Meyer, N E Madias
Pageof 7